Chemohormonal therapy as primary treatment for metastatic prostate cancer: a randomized study of estramustine phosphate plus luteinizing hormone-releasing hormone agonist versus flutamide plus luteinizing hormone-releasing hormone agonist.
about
Chemotherapy for hormone-refractory prostate cancerPrevalence of Prostate Cancer Clinical States and Mortality in the United States: Estimates Using a Dynamic Progression ModelEfficacy and Safety of Combined Androgen Deprivation Therapy (ADT) and Docetaxel Compared with ADT Alone for Metastatic Hormone-Naive Prostate Cancer: A Systematic Review and Meta-AnalysisAndrogen-deprivation therapy alone versus combined with radiation therapy or chemotherapy for nonlocalized prostate cancer: a systematic review and meta-analysisPhase III trial of androgen ablation with or without three cycles of systemic chemotherapy for advanced prostate cancer.Chemotherapy for metastatic castration-sensitive prostate cancer.[Drug therapy of hormone-sensitive metastatic prostate cancer : Consensus paper of the AKO/AUO].Network meta-analysis of the efficacy and adverse effects of several treatments for advanced/metastatic prostate cancer.
P2860
Q24243797-6B190E6A-9958-474B-A184-539D26641BB6Q26783861-37A54891-A7C3-4BE3-8B52-7971DB75B9B0Q28550301-4F65C3B9-4503-4A9B-A563-790F127F0FBCQ36530173-4D3B6776-E8E5-4759-B473-76A2DB25F92FQ37395384-39F91434-4EC2-4440-94A4-29B3CF3A3237Q38877513-20CB34D5-712D-4113-993A-12AC51CB110FQ40644662-8BCADDC8-7C2F-436A-AAAC-AD75D661280CQ41708691-CF2295D2-A9C1-4A9F-AFC4-103E1C4696FB
P2860
Chemohormonal therapy as primary treatment for metastatic prostate cancer: a randomized study of estramustine phosphate plus luteinizing hormone-releasing hormone agonist versus flutamide plus luteinizing hormone-releasing hormone agonist.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Chemohormonal therapy as prima ...... one-releasing hormone agonist.
@en
Chemohormonal therapy as prima ...... one-releasing hormone agonist.
@nl
type
label
Chemohormonal therapy as prima ...... one-releasing hormone agonist.
@en
Chemohormonal therapy as prima ...... one-releasing hormone agonist.
@nl
prefLabel
Chemohormonal therapy as prima ...... one-releasing hormone agonist.
@en
Chemohormonal therapy as prima ...... one-releasing hormone agonist.
@nl
P2093
P2860
P1476
Chemohormonal therapy as prima ...... one-releasing hormone agonist.
@en
P2093
Kurume-Kumamoto Estracyt Study Group
Kyogo Itoh
Masaki Yoshida
Masanori Noguchi
Shinshi Noda
Shoichi Ueda
Taizo Shiraishi
P2860
P304
P356
10.1111/J.1442-2042.2004.T01-1-00748.X
P577
2004-02-01T00:00:00Z